Pain Relief Therapeutics
Pain Relief Therapeutics Market By Therapeutics (Non-steroidal Anti-inflammatory Drugs, Anesthetics, Anticonvulsant, Antimigrane Agents, Antidepressants), By Indication (Arthritic Pain, Cancer Pain, Neuropathic Pain, Chronic back Pain, Post-operative Pain), By Distribution channel (Hospital Pharmacy, Drug Stores, Online Pharmacy), Industry Analysis, Trends, and Forecast 2021-2027Report ID: BMRC 278 | Number of pages: 200 | Publish Date: May 2019 | Category: Lifesciences and Healthcare
Pain Relief Therapeutics Market: The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics Market. Global Pain Relief Therapeutics Market Reports – An unpleasant sensation that can range from mild to localized discomfort and which occurs due to tissue damage or illness.The duration of pain differs from short term known as acute pain to long term known as chronic pain.Pain that occurs quickly, but lasts for shorter duration of time such as 3 to 6 months is called Acute Pain.Pain that lasts for more than 12 weeks and is arising from an initial injury, such as a back sprain is called as Chronic Pain. The symptoms of Pain are weakness, fever, muscle cramps,Abdominal pain, Blood in stool,Cough, Diarrhea, Difficulty swallowing and Dizziness.There is no such test that can measure and locate pain with precision. So, doctors relay on the patient’s own description of the type, timing, and location of pain. Description of pain such as sharp or dull, constant or on-and-off, or burning or aching might give the best clues to the cause of the pain. These descriptions are called as the pain history, taken during the start of the evaluation of a patient with pain. Moreover chronic pain can occurs in a various parts of body and for different reasons so patients and their doctors must work together to recognize the causes and symptoms of that pain and how it can be treated in early stage. Although technology can help doctors for diagnosis, the best treatment plans are personalized to the person, with efforts from healthcare team, who all have different training backgrounds and understand chronic pain. The person suffering from pain and his or her loved ones also must be actively involved in the treatment. Drugs used to treat Pain are Acetaminophen, Codeine, Ibuprofen, Morphine and many mores. Global Pain Relief Therapeutics Market is segmented on the basis of Therapeutics, Indication, Distribution channel and Geography. On the Basis of Therapeutics, Global Pain Relief Therapeutics Market is classified as Non-steroidal Anti-inflammatory Drugs (NSAID’s), Anesthetics, Anticonvulsant, Antimigrane Agents, Antidepressants, Opioids, Nonnarcotic Analgesics and Others. On the basis of Indication Global Pain Relief Therapeutics Market is classified into Arthritic Pain, Cancer Pain, Neuropathic Pain, Chronic back Pain, Post-operative Pain, Migraine, Fibromyalgia andothers. On the basis of Distribution channelGlobal Pain Relief Therapeutics Market is classified asHospital Pharmacy, Drug Stores, Online Pharmacy and Other. The regions covered in Global Pain Relief Therapeutics Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc. Key Players for Global Pain Relief Therapeutics Market Reports – Global Pain Relief Therapeutics Market reports cover prominent players like Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions, Inc., Purdue Pharma L.P., Pfizer, Inc., F. Hoffmann La Roche Ltd., Merck & Co. Inc., Johnson & Johnson, GlaxoSmithKline Plc., Allergen Inc., Bayer AG, Bristol-Myers Squibb, Valeant Pharmaceuticals International Inc., BoehringerIngelheim, Sorrento Therapeutics, WEX Pharmaceuticals, Mallinckrodt plc, Teva Pharmaceuticals and Zynerba Pharmaceuticals, AstraZeneca Inc., Depomed Inc., MaynePharma Group Limited, Sanofi Inc., Beiersdorf AG, Astellas Pharmaceuticals Inc., Durect Corporation, AcelRx Pharmaceuticals, Inc., Acorda Therapeutics Inc., Achelios Therapeutics, Amgen Inc., Cara Therapeutics, Avanir Pharmaceuticals Inc., Axsome Therapeutics Inc., BioDelivery Sciences International, COLLEGIUM Pharmaceutical Inc., Centrexion Therapeutics, Daiichi Sankyo Company Ltd., Egalet Corporation, EpiCept, FemmePharma, Flexion Therapeutics Inc., Galapagos NV, Heron Therapeutics, Helsinn Healthcare, Sainsys Therapeutics Inc, Iroko Pharmaceuticals, KemPharm Inc., Mesoblast Ltd, Nektar Therapeutics, NeurAxon, Newron Pharmaceuticals, Olatec Industries, Otsuka Pharmaceutical, PLxPharma, Orexo AB, Regeneron Pharmaceuticals Inc., RecroPharmaInc, Relmada TherapeuticsInc, Scintilla Pharmaceuticals Inc.and others. Global Pain Relief Therapeutics Market Dynamics – Rising geriatric population and increasing incidence of chronic diseases such as nerve damage, depression, epilepsy, bone or joint pain, and injuries etc., are key factors driving growth of Global Pain Relief Therapeutics Market. Changing lifestyle, early onset of aging, and increasing awareness about of pain management therapeutics are other growth drivers of the Global Pain Relief Therapeutics Market. However, side-effects such as allergic reactions including rash, itching and swelling of face, throat and tongue caused by certain Pain Relief Therapeutics is a key factor restraining growth of the Global Pain Relief Therapeutics Market. Additionally, availability of other generic pain relief therapeutics, increasing preference for this genericpain relief the rapeuticsby the general population and Drug Abuse are major factors that expected to hinder growth of the Global Pain Relief Therapeutics Market over the forecast period. Additionally, favorable regulations are playing a key role in the increased rate of development, approval, and commercialization of novel molecule combinations and drug delivery techniques in the Global Pain Relief Therapeutics Market sector. The advancements in drug development and the investigation of a large number of regulatory healthcare reforms, favoring development of methods for the improved diagnosis and treatment of chronic pain, will help the Global Pain Relief Therapeutics Market tread along a promising growth path in the next few years. Global Pain Relief Therapeutics Market Regional Analysis – North America held the leading share in the Global Pain Relief Therapeutics Market. The growth of this regional market is mainly because of favorable reimbursement policies for prescription drugs used for Pain Relief Therapeutics and availability of a spectrum of over-the-counter drugs for Pain Relief Therapeutics.The existence of better drug manufacturers is expected to have positive impact on the North America market for Pain Relief Therapeutics in the future.Asia Pacific is expected to observe the leading growth rate due to a growing geriatric population, rising awareness to health problems in a timely manner and increased focus of leading companies to tap into growth opportunities in China and India.Furthermore, increase in awareness through various government and NGO campaigns of disease and government initiatives for improving health care facilities are expected to boost the regional market to a certain extent. Key Benefits for Global Pain Relief Therapeutics Market Reports – Global Pain Relief Therapeutics Market report covers in depth historical and forecast analysis. Global Pain Relief Therapeutics Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level. Global Pain Relief Therapeutics Market report helps to identify opportunities in market place. Global Pain Relief Therapeutics Market report covers extensive analysis of emerging trends and competitive landscape. Pain Relief Therapeutics Market Segmentation By Therapeutics Non-steroidal Anti-inflammatory Drugs (NSAID’s) Anesthetics Anticonvulsant Antimigrane Agents Antidepressants Opioids Nonnarcotic Analgesics Others By Indication Arthritic Pain Cancer Pain Neuropathic Pain Chronic back Pain Post-operative Pain Migraine Fibromyalgia Others By Distribution channel Hospital Pharmacy Drug Stores Online Pharmacy Others By Region North America U.S. Mexico Canada Europe UK France Germany Italy Asia Pacific China Japan India Southeast Asia Latin America Brazil The Middle East and Africa GCC Africa Rest of Middle East and Africa Pain Relief Therapeutics Market Key Players Novartis AG Eli Lilly & Company Abbott Laboratories Endo Health Solutions Inc. Purdue Pharma L.P. Pfizer Inc. Hoffmann La Roche Ltd. Merck & Co. Inc. Johnson & Johnson GlaxoSmithKline Plc. Allergen Inc. Bayer AG
Interested in this report?
Get your sample now!